Cardiovascular reactivity of rats during the development of salt hypertension. I. the response to polypeptides.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects*; D004878:Ergotamine / Q000494:pharmacology; D005260:Female; D006321:Heart / Q000187:drug effects*; D006955:Hypernatremia; D006973:Hypertension / Q000139:chemically induced*; D007275:Injections, Intravenous; D008297:Male; D010121:Oxytocin / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology*; D051381:Rats; D012965:Sodium Chloride / Q000494:pharmacology*; D014628:Vagotomy; D014667:Vasopressins / Q000494:pharmacology
D010455:Peptides; D014667:Vasopressins; D000804:Angiotensin II; D012965:Sodium Chloride; D010121:Oxytocin; D001285:Atropine; D004878:Ergotamine